349 related articles for article (PubMed ID: 22723958)
21. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
[TBL] [Abstract][Full Text] [Related]
22. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.
Pan PY; Gu P; Li Q; Xu D; Weber K; Chen SH
J Immunol; 2004 Apr; 172(8):4779-89. PubMed ID: 15067054
[TBL] [Abstract][Full Text] [Related]
23. Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation.
Kim KD; Kim JK; Kim SJ; Choe IS; Chung TH; Choe YK; Lim JS
Arch Pharm Res; 1999 Aug; 22(4):340-7. PubMed ID: 10489871
[TBL] [Abstract][Full Text] [Related]
24. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
25. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
Parajuli P; Mathupala S; Sloan AE
Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
[TBL] [Abstract][Full Text] [Related]
26. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
Nguyen-Pham TN; Yang DH; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Lee JJ
Cell Mol Immunol; 2012 Jan; 9(1):45-53. PubMed ID: 21822297
[TBL] [Abstract][Full Text] [Related]
27. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.
Melki MT; Saïdi H; Dufour A; Olivo-Marin JC; Gougeon ML
PLoS Pathog; 2010 Apr; 6(4):e1000862. PubMed ID: 20419158
[TBL] [Abstract][Full Text] [Related]
28. Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathway.
Nagasaki E; Takahara A; Koido S; Sagawa Y; Aiba K; Tajiri H; Yagita H; Homma S
J Immunother; 2010 Jun; 33(5):467-74. PubMed ID: 20463601
[TBL] [Abstract][Full Text] [Related]
29. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
30. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
31. Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists.
Uchida T; Scumpia PO; Murasko DM; Seki S; Woulfe S; Clare-Salzler MJ; Moldawer LL
J Immunol; 2007 Mar; 178(6):3886-92. PubMed ID: 17339488
[TBL] [Abstract][Full Text] [Related]
32. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
33. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
[TBL] [Abstract][Full Text] [Related]
34. Influence of autologous dendritic cells on the in-vitro expansion and functions of peripheral blood NK cells.
Li XH; Wu XX; Wu YM; Da WM; Li M; Cai B; Zhao XL; Dou LP; Gao CJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):72-80. PubMed ID: 25409754
[TBL] [Abstract][Full Text] [Related]
35. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells.
Balza E; Zanellato S; Poggi A; Reverberi D; Rubartelli A; Mortara L
Eur J Immunol; 2017 Apr; 47(4):743-753. PubMed ID: 28198545
[TBL] [Abstract][Full Text] [Related]
37. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
38. Cellular cytotoxicity is a form of immunogenic cell death.
Minute L; Teijeira A; Sanchez-Paulete AR; Ochoa MC; Alvarez M; Otano I; Etxeberrria I; Bolaños E; Azpilikueta A; Garasa S; Casares N; Perez Gracia JL; Rodriguez-Ruiz ME; Berraondo P; Melero I
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217765
[TBL] [Abstract][Full Text] [Related]
39. Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.
Batalla EI; Pino Martínez AM; Poncini CV; Duffy T; Schijman AG; González Cappa SM; Alba Soto CD
J Innate Immun; 2013; 5(5):494-504. PubMed ID: 23689360
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
